Price
No data yet.
Social Signal Score
Revenue
$15.48B+99.55%Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Beta
- 0.66
- Country
- US
Financials
Revenue
$15.48B+99.6%Net Income
$1.00B+413.6%EBITDA
$1.51B+191.5%Free Cash Flow
$-817.00M-361.4%EPS (diluted)
$3.03+621.4%Shares Outstanding (diluted)
330.20M-28.5%Operating Expenses
$2.74BCash & Debt
$9.41BReturn of Capital
$164.00MDividend per Share
$0.50Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2017 | $60.53B | $1.90B | $9.16 |
| 2016 | $63.16B | $2.27B | $6.41 |
| 2015 | $60.34B | $2.39B | $6.84 |
| 2014 | $58.00B | $2.04B | $5.74 |
| 2013 | $47.29B | $1.91B | $5.38 |
| 2012 | $36.60B | $1.66B | $4.87 |
| 2011 | $33.78B | $1.99B | $5.22 |
| 2010 | $34.25B | $1.77B | $4.25 |
| 2009 | $34.76B | $1.28B | $2.96 |
| 2008 | $30.95B | $1.38B | $3.00 |
| 2007 | $27.60B | $1.83B | $3.60 |
| 2006 | $25.15B | $1.70B | $3.12 |
| 2005 | $22.49B | $1.63B | $2.82 |
| 2004 | $19.90B | $2.25B | $3.71 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AET's reported EPS growth of 7.2% a year over 13 years.
- EPS in 5 years
- $8.25
- Implied price
- $82.48
- Return from $106.35
- -5.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $41.01 — -61.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| -2.8% | -22.2% | -17.6% | -13.8% | -10.6% | -7.8% |
| 2.2% | -18.2% | -13.3% | -9.4% | -6.0% | -3.1% |
| 7.2% | -14.2% | -9.1% | -5.0% | -1.4% | 1.7% |
| 12.2% | -10.2% | -4.9% | -0.5% | 3.2% | 6.4% |
| 17.2% | -6.2% | -0.6% | 3.9% | 7.8% | 11.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newszacks.com·17h ago·Positive
Here's How CVS Is Focusing on Aetna's Profitability Turnaround CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
View source ↗
Insider trading
Open-market buys and sells by AET officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.